Intelligence Platform
Patents
Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7744902
Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal
granted patentUS 7741437
P. ariasi polypeptides, p. perniciosus polypeptides and methods of use
granted patentUS 7741431
Liposomes containing novel targeting and/or fusogenic peptides, preparations containing th
granted patentUS 7741113
Cell-specific molecule and method for importing DNA into osteoblast nuclei
granted patentUS 7741063
Toxoplasma gondii oocyst protein
granted patentUS 7740889
Bacteriocins and novel bacterial strains
granted patentUS 7736656
Immunogenic compositions and vaccines for Ebola
granted patentUS 7731939
Vaccine compositions and adjuvant
granted patentUS 7731975
Chimeric filovirus glycoprotein
granted patentUS 7731971
Enhanced CTL epitope-containing HIV-1 reverse transcriptase polypeptides
granted patentUS 7731953
Methods for use of TSLP and agonists and antagonists thereof
granted patentUS 7727514
Compositions comprising a UV-absorbing chromophore
granted patentUS 7723022
Immunostimulatory nucleic acid molecules
granted patentUS 7723500
Immunostimulatory nucleic acid molecules
granted patentUS 7723311
Delivery of bioactive substances to target cells
granted patentUS 7723111
Activated dual specificity lymphocytes and their methods of use
granted patentUS 7723096
Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the
granted patentUS 7722889
Plasmodium liver stage antigens
granted patentUS 7718424
AAV4 vector and uses thereof
granted patentUS 7718779
Prophylactic and therapeutic monoclonal antibodies
granted patentUS 7718183
Proteins with repetitive bacterial-Ig-like (big) domains present in Leptospira species
granted patentUS 7718196
Rapamycin-resistant T cells and therapeutic uses thereof
granted patentUS 7713529
Methods for treating and preventing infectious disease
granted patentUS 7709002
Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes
granted